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Background: Multiple viruses, including human immunodeficiency virus, Epstein Barr virus (EBV) and mouse
mammary tumour virus have been identified in human milk. High risk human papillomavirus (HPV) sequences have
been identified in breast cancer. The aim of this study is to determine if viral sequences are present in human milk
from normal lactating women.
Findings: Standard (liquid) and in situ polymerase chain reaction (PCR) techniques were used to identify HPV
and EBV in human milk samples from normal lactating Australian women who had no history of breast cancer.
High risk human papillomavirus was identified in milk samples of 6 of 40 (15%) from normal lactating
women - sequencing on four samples showed three were HPV 16 and one was HPV 18. Epstein Barr virus was
identified in fourteen samples (33%).
Conclusion: The presence of high risk HPV and EBV in human milk suggests the possibility of milk transmission of
these viruses. However, given the rarity of viral associated malignancies in young people, it is possible but unlikely,
that such transmission is associated with breast or other cancers.
Keywords: Human papillomavirus, Epstein barr virus, Human milkHigh risk human papillomavirus (HPV) is primarily con-
sidered as a sexually transmitted infection [1]. However,
a range of other means of transmission have been docu-
mented. These include white blood cells [2] oral mucosa
[3] intrauterine, placenta and cord blood [4]. High risk
HPV type 16 has been identified in 4 to 8% of human
milk samples [5,6]. On the other hand, in a recent study
Mammas et al [7] did not identify any high risk HPV
sequences in human milk from Greek women. Other
means of HPV transmission in addition to sexually
transmitted infections are important factors to be con-
sidered in the context of primary prevention of HPV by
vaccines. We have become aware of recent, but unpub-
lished experimental findings, that Epstein Barr virus
(EBV) has the capacity to enhance the oncogenicity of
HPV associated cervical cancer cells [8]. For this reason,
in addition to HPV, we also investigated the presence of
EBV in human milk samples.
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reproduction in any medium, provided the orfrom normal lactating Australian women. These findings
have in part, been previously reported [9].
Methods
This project was formally approved by the University of
New South Wales, Australia, Human Research Ethics
Committee (HREC 05163). All participants gave written,
informed, prior consent.
Samples of human breast milk were collected from
40 lactating Australian women. None of these women
had a history of breast cancer. The milk was expressed
into sterile 50ml falcon tubes. To prevent contamin-
ation, the milk samples were then transferred into
1.5ml eppendorf tubes using filtered tips for all proce-
dures. The 1.5ml tubes were centrifuged at 2,000 rpm
for 10 minutes. The whey and fat were removed and
the pellet was washed twice with phosphate buffered sa-
line (PBS). The pellet was then resuspended in 200μl of
PBS. 10μl 1M Tris pH8 and 10μl of 0.5M ethylenedia-
minetetraacetic acid (EDTA) were added to 100ul of
the PBS based solution, the mixture vortexed and 2μl
2% sodium dodecyl sulfate (SDS) and 1μl proteinase K
(10mg per ml) added. The tubes were heated at 55oCtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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by 2 chloroform washes were performed before an alco-
hol precipitation. The DNA pellet was resuspended in
Tris-EDTA (TE) and checked with a β -globin PCR
analysis. A reagent blank of bovine skim milk was used
for each set of milk extractions.
DNA integrity was confirmed by standard PCR using
β-globin primers G073 (50-GAAGAGCCAAGGACAGG
TAC-30) and G074 (50-CAACTTCATCCACGTTCACC-
30). HPV screening used nested PCR with outer primers,
PGMY, and inner primers GP as per Heng et al [10].
For EBV screening nested primers (EB3 5’-AAGGAG
GGTGGTTTGGAAAG, EB4 5’-AGACAATGGACTC
CCTTAGC) and (EB1 5 ’-ATCGTGGTCAAGGAGGT
TCC, EB2 5’-ACTCAATGGTGTAAGACGAC) were
used as per Cinque et al [11]. The cycling conditions
for the above PCRs were 95°C for 3 min; followed by
35 cycles at 95°C for 30 seconds; 55°C for 30 seconds;
72°C for one minute and a final extension at 72°C for
five minutes.
In situ PCR was attempted on a different set of milk
samples. To prepare the milk samples for in-situ PCR,
drops of the resuspended cell pellet in PBS were dried
on glass slides followed by fixation in ice cold methanol
for 5 minutes. An H&E stain of the slides identified the
milk samples which contained cells. Selected samples
were treated with 0.1% triton X digestion for 10 minutes
at room temperature. The primers used for HPV in situ
PCR were the outer primers used for the HPV screening.
75 μL of PCR mixture was prepared for each slide with
the concentration of the reagents as follows: 7.5 μL
10X PCR buffer (Roche Diagnostics), 0.375 μL dNTP
mixture (dATP, dGTP, dCTP; 25 mM/ml each), 0.33 μL
digoxigenin (DIG) – 11 – dUTP (25 nM, Roche Diag-
nostics), 6 μL MgSO4 (100 mM, Roche Diagnostics),        M       1        2        3        4        5      
M 12 13 14 15 16
Figure 1 Outcomes of standard liquid PCR using HPV primers. 2% aga
Hinf 1 size standard (1,419 bp, 517 bp plus 396 bp, 214 bp, 75/65 bp). 1-40
blank after 2 round. B2= no DNA PCR blank after 1 round. +=positive con1 μL (10pM) forward primer and 1 μL (10pM) reverse
primer, 1 μL Taq Polymerase (Roche Diagnostics) and
sterilized water. The thermocycling conditions were as
follows: initial denaturation at 95°C for three minutes;
35 cycles at 95°C for one minute, 55°C for one mi-
nute and 72°C for one minute and a final extension
at 72°C for five minutes.
Findings
Six of the forty milk samples (15%) were positive for
HPV. Sequencing of four samples showed three were
positive for HPV type 16 and one was positive for HPV
18 (Figures 1 and 2). Some variations in the HPV 16
sequences were present. While mutations at bases 6689
and 6715 are common, the mutation at base 6657, al-
though reported before in AF548851 to be Y, has not
been found to be an A. The HPV 18 sequence was iden-
tical to AY 262282.
Fourteen of the 40 milk samples (33%) were positive
for EBV. Sequencing of two samples showed identical
sequences to an EBNA 1 region of EBV strain B95-8.
One of these samples was also positive for HPV 18.
In-situ PCR on a centrifuged milk sample showed high
risk HPV in the nuclei of epithelial cells (Figure 3).
There were differing amounts of cellular debris in each
sample. Some appeared to contain no intact cells. The
number of whole cells was very low and some were seen
as clumps. The HPV positive cells seen in Figure 3 are
from approximately 5% of the volume of a 1.5 ml milk
pellet. There were approximately 10 HPV positive cells
in the whole milk sample, no negative cells were
observed. In-situ PCR was not performed on all the milk
samples because of the low copy number of cells and
large amounts of debris which were seen on the H&E.
In-situ PCR for EBV was not performed.  6        7        8         9        10     11 
RB + B1 B2
rose gel of Nested PCR products from breast milk samples. M=Puc
= samples (only 1-16 shown). RB= reagent blank. B1= no DNA PCR
trol (HeLa DNA).
HPV 16      TTTGTTACTGTTGTTGATACTACACGCAGTACAAATATGTCATTATGTGCTGCCATATCT 
Sample A    TTTGTTACTGTGGTAGATACTACACGCAGTACAAATAAGTCATTATGTGCTGCCATATCT  
Sample B   TTTGTTACTGTGGTAGATACTACACGCAGTACAAATATGTCATTATGTGCTGCCATATCT 
Sample C           TGTCATTATGTGCTGCCATATCT 
HPV 16      ACTTCAGAAACTACATATAAAAATACTAACTTTAAGGAGTACCTACGACATGGG  
Sample A   ACTTCAGAAACTACATATAAAAATACTAACTTTAAGGAGTACCTACGACATGGG  
Sample B   ACTTCAGAAACTACATATAAAAATACTAACTTTAAGGAGTACCTACGACATGGG 
Sample C   ACTTCAGAAACTACATATAAAAATACTAACTTAAAGGAGTACCTACGACATGGG 
HPV 18   TTTAACAATATGTGCTTCTACACAGTCTCCTGTACCTGGGCAATATGATGCTACCAAATTT 
SAMPLE D TTTAACAATATGTGCTTCTACACAGTCTCCTGTACCTGGGCAATATGATGCTACCAAATTT 
HPV 18       AAGCAGTATAGCAGACATGTT                
Sample D   AAGCAGTATAGCAGACATGTT
EBV         TTGCAGAAGGTTTAAGAGCTCTCCTGGCTAGGAGTCACGTAGAAAGGACTACCGACGAAG 
Sample D    TTGCAGAAGGTTTAAGAGCTCTCCTGGCTAGGAGTCACGTAGAAAGGACTACCGACGAAG 
Sample E    TTGCAGAAGGTTTAAGAGCTCTCCTGGCTAGGAGTCACGTAGAAAGGACTACCGACGAAG 
EBV        GAACTTGGGTCGCCGGTGTGTTCGTATATGGAGGTAGTAAGACCTCCCTTTACAACCTAA 
Sample D    GAACTTGGGTCGCCGGTGTGTTCGTATATGGAGGTAGTAAGACCTCCCTTTACAACCTAA 
Sample E    GAACTTGGGTCGCCGGTGTGTTCGTATATGGAGGTAGTAAGACCTCCCTTTACAACCTAA  
EBV         GGCGAGGAACTGCCCTTGCTATTCCACAATGTC 
Sample D    GGCGAGGAACTGCCCTTGCTATTCCACAATGTC        
Sample E    GGCGAGGAACTGCCCTTGCTATTCCACAATGTC          
Figure 2 Sequencing results. Three HPV positive samples A,B,C compared to HPV 16 (FJ610151- bases 6627 to 6740) with differences shown in
red, and one positive HPV sample D, compared to HPV 18 (AY262282). Samples C and D were only sequenced from one direction. Also
sequences for two EBV positive samples D and E compared to V01555- (bases 109391- 109543) . Note that Sample D was positive for HPV and
EBV. Primer sequences have been omitted.
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We have demonstrated that both high risk HPVs and
EBV may be present in the milk of a minority of normal
lactating women, none of whom have had prior breast
cancer. These findings are very similar to those of Sar-
kola et al [5] in Finland and Cazzaniga et al [6] in Italy
and are in contrast to the negative findings of Mammas
et al [7] in Greece.
Other viruses including human immunodeficiency
virus (HIV), mouse mammary tumour virus and EpsteinFigure 3 HPV positive epithelial cell located in human milk by in situ
Some cells can be seen as groups. Dark blue colour indicates the incorpora
added (not shown) had no blue colour in the cells.Barr virus have previously been identified in human milk
[12-14]. Transmission of each of these viruses by human
milk to newborn infants is a possibility. Mother-to-child
transmission of HIV-1 infection during exclusive breast-
feeding in the first 6 months of life is a common occur-
rence in Africa [12]. It is also known that HPV can be
transmitted from infected mothers to their newborn ba-
bies with persistence of the virus into childhood [15]. It
is not known whether HPV transmission can be from
infected human milk.PCR. The images on the right have been cropped to show cells only.
tion of Dig dUTP in the PCR. The negative control with no primers
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http://www.biomedcentral.com/1756-0500/5/477High risk HPVs have been identified in both normal
breast tissues and breast tumours of Australian women
[10]. Therefore it is possible that HPV positive normal
breast epithelial cells can be shed into the milk of nor-
mal lactating women.
The identification of viral sequences does not prove
that these viruses are biologically active. The identifica-
tion of HPV viral transcripts in human milk would be of
future value. With respect to HPV such identification
can indicate whether the HPV E6:L1 mRNA expression
ratio is high (high E6 low L1) which is an indication that
HPV is integrated and probably transforming, that is,
the HPV is biologically active within the breast milk epi-
thelial cells.
It is not known whether HPVs have long latency peri-
ods [16]. It is also unknown whether ingested HPVs can
survive passage into the gut. HPVs are known to collab-
orate with Epstein Barr viruses which can have pro-
longed latency periods [8]. Therefore there are no
current answers to the question whether HPVs and EBV
ingested in infancy can lead to later oncogenicity.
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